The ferroportin Q248H mutation protects from anemia, but not malaria or bacteremia

Science Advances

Volumn 5, Issue 9, 2019, Pages

  Muriuki, John Muthii ^a   Mentzer, Alexander J ^b   Band, Gavin ^b   Gilchrist, James J ^b,c   Carstensen, Tommy ^d   Lule, Swaib A ^e   Goheen, Morgan M ^f,g   Joof, Fatou ^f   Kimita, Wandia ^a   Mogire, Reagan ^a   Cutland, Clare L ^h   Diarra, Amidou ⁱ   Rautanen, Anna ^b   Pomilla, Cristina ^d   Gurdasani, Deepti ^d   Rockett, Kirk ^b   Mturi, Neema ^a   Ndungu, Francis M ^a   G Scott, J Anthony ^a,e   Sirima, Sodiomon B ⁱ   Morovat, Alireza ^j   Prentice, Andrew M ^f   Madhi, Shabir A ^h   Webb, Emily L ^e   Elliott, Alison M ^e   Bejon, Philip ^a,b   Sandhu, Manjinder S ^d   Hill, Adrian V S ^b,k   Kwiatkowski, Dominic P ^b,d   Williams, Thomas N ^a,b,l   Cerami, Carla ^f   Atkinson, Sarah H ^a,c   more..

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ Centre de Recherche Action en Sante GRAS   (Burkina Faso)

^j OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^k UNIVERSITY OF OXFORD   (United Kingdom)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BACTERIOLOGY; BLOOD; IRON; MAMMALS;

EX-VIVO; HEPCIDIN; HUMAN STUDY; INDUCED DEGRADATION; IRON ACQUISITION; IRON DEFICIENCY; MALARIA PARASITE;

DISEASES;

CATION TRANSPORT PROTEIN; IRON; METAL TRANSPORTING PROTEIN 1;

AMINO ACID SUBSTITUTION; ANEMIA; BACTEREMIA; CLINICAL TRIAL; ERYTHROCYTE; FEMALE; GENETICS; HUMAN; INFANT; MALARIA; MALE; METABOLISM; MISSENSE MUTATION; MULTICENTER STUDY; NEWBORN;

AMINO ACID SUBSTITUTION; ANEMIA; BACTEREMIA; CATION TRANSPORT PROTEINS; ERYTHROCYTES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; IRON; MALARIA; MALE; MUTATION, MISSENSE;

EID: 85072121463     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.aaw0109     Document Type: Article

References (40)

1. M. F. Barber, N. C. Elde, Escape from bacterial iron piracy through rapid evolution of transferrin. Science 346, 1362–1366 (2014).
2. A. Donovan, A. Brownlie, Y. Zhou, J. Shepard, S. J. Pratt, J. Moynihan, B. H. Paw, A. Drejer, B. Barut, A. Zapata, T. C. Law, C. Brugnara, S. E. Lux, G. S. Pinkus, J. L. Pinkus, P. D. Kingsley, J. Palis, M. D. Fleming, N. C. Andrews, Z. I. Leonard, Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776–781 (2000).
3. D.-L. Zhang, J. Wu, B. N. Shah, K. C. Greutélaers, M. C. Ghosh, H. Ollivierre, X.-Z. Su, P. E. Thuma, G. Bedu-Addo, F. P. Mockenhaupt, V. R. Gordeuk, T. A. Rouault, Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk. Science 359, 1520–1523 (2018).
4. S. Nekhai, M. Xu, A. Foster, I. Kasvosve, S. Diaz, R. F. Machado, O. L. Castro, G. J. Kato, J. G. Taylor VI, V. R. Gordeuk, Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin. Haematologica 98, 455–463 (2013).
5. J. A. McGregor, M. Shayeghi, C. D. Vulpe, G. J. Anderson, A. Pietrangelo, R. J. Simpson, A. T. Mckie, Impaired iron transport activity of ferroportin 1 in hereditary iron overload. J. Membr. Biol. 206, 3–7 (2005).
6. L. M. Schimanski, H. Drakesmith, A. T. Merryweather-Clarke, V. Viprakasit, J. P. Edwards, E. Sweetland, J. M. Bastin, D. Cowley, Y. Chinthammitr, K. J. H. Robson, A. R. M. Townsend, In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096–4102 (2005).
7. H. Drakesmith, L. M. Schimanski, E. Ormerod, A. T. Merryweather-Clarke, V. Viprakasit, J. P. Edwards, E. Sweetland, J. M. Bastin, D. Cowley, Y. Chinthammitr, K. J. H. Robson, A. R. M. Townsend, Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106, 1092–1097 (2005).
8. Malaria Genomic Epidemiology Network, Reappraisal of known malaria resistance loci in a large multicenter study. Nat. Genet. 46, 1197–1204 (2014).
9. J. J. Gilchrist, A. Rautanen, B. P. Fairfax, T. C. Mills, V. Naranbhai, H. Trochet, M. Pirinen, E. Muthumbi, S. Mwarumba, P. Njuguna, N. Mturi, C. L. Msefula, E. N. Gondwe, J. M. MacLennan, S. J. Chapman, M. E. Molyneux, J. C. Knight, C. C. A. Spencer, T. N. Williams, C. A. MacLennan, J. A. G. Scott, A. V. S. Hill, Risk of nontyphoidal Salmonella bacteraemia in African children is modified by STAT4. Nat. Commun. 9, 1014 (2018).
10. A. Bah, R. Wegmuller, C. Cerami, L. Kendall, S.-R. Pasricha, S. E. Moore, A. M. Prentice, A double blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron. BMC Pregnancy Childbirth 16, 157 (2016).
11. R. Wegmüller, A. Bah, L. Kendall, M. M. Goheen, S. Mulwa, C. Cerami, D. Moretti, A. M. Prentice, Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: A double-blind randomised controlled trial. BMC Pediatr. 16, 149 (2016).
12. E. Muthumbi, S. C. Morpeth, M. Ooko, A. Mwanzu, S. Mwarumba, N. Mturi, A. O. Etyang, J. A. Berkley, T. N. Williams, S. Kariuki, J. A. G. Scott, Invasive salmonellosis in Kilifi, Kenya. Clin. Infect. Dis. 61, S290–S301 (2015).
13. The 1000 Genomes Project Consortium, A global reference for human genetic variation. Nature 526, 68–74 (2015).
14. R. W. Snow, B. Sartorius, D. Kyalo, J. Maina, P. Amratia, C. W. Mundia, P. Bejon, A. M. Noor, The prevalence of Plasmodium falciparum in sub-Saharan Africa since 1900. Nature 550, 515–518 (2017).
15. V. R. Gordeuk, A. Caleffi, E. Corradini, F. Ferrara, R. A. Jones, O. Castro, O. Onyekwere, R. Kittles, E. Pignatti, G. Montosi, C. Garuti, I. T. Gangaidzo, Z. A. R. Gomo, V. M. Moyo, T. A. Rouault, P. MacPhail, A. Pietrangelo, Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene. Blood Cells Mol. Dis. 31, 299–304 (2003).
16. I. Kasvosve, Z. A. R. Gomo, K. J. Nathoo, P. Matibe, B. Mudenge, M. Loyevsky, V. R. Gordeuk, Effect of ferroportin Q248H polymorphism on iron status in African children. Am. J. Clin. Nutr. 82, 1102–1106 (2005).
17. C. A. Rivers, J. C. Barton, V. R. Gordeuk, R. T. Acton, M. R. Speechley, B. M. Snively, C. Leiendecker-Foster, R. D. Press, P. C. Adams, G. D. McLaren, F. W. Dawkins, C. E. McLaren, D. M. Reboussin, Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Blood Cells Mol. Dis. 38, 247–252 (2007).
18. I. Kasvosve, U. Tshwenyego, T. Phuthego, G. Koto, M. Zachariah, N. G. Nyepetsi, M. S. Motswaledi, Serum ferritin concentration is affected by ferroportin Q248H mutation in Africans. Clin. Chim. Acta 444, 257–259 (2015).
19. F. Masaisa, C. Breman, J. B. Gahutu, J. Mukiibi, J. Delanghe, J. Philippé, Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating serum hepcidin levels in Rwandese HIV-positive women. Ann. Hematol. 91, 911–916 (2012).
20. M. A. Baker, D. Wilson, K. Wallengren, A. Sandgren, O. Iartchouk, N. Broodie, S. D. Goonesekera, P. C. Sabeti, M. B. Murray, Polymorphisms in the gene that encodes the iron transport protein ferroportin 1 influence susceptibility to tuberculosis. J. Infect. Dis. 205, 1043–1047 (2012).
21. R. Nielsen, J. M. Akey, M. Jakobsson, J. K. Pritchard, S. Tishkoff, E. Willerslev, Tracing the peopling of the world through genomics. Nature 541, 302–310 (2017).
22. E. L. Webb, P. A. Mawa, J. Ndibazza, D. Kizito, A. Namatovu, J. Kyosiimire-Lugemwa, B. Nanteza, M. Nampijja, L. Muhangi, P. W. Woodburn, H. Akurut, H. Mpairwe, M. Akello, N. Lyadda, J. Bukusuba, M. Kihembo, M. Kizza, R. Kizindo, J. Nabulime, C. Ameke, P. B. Namujju, R. Tweyongyere, M. Muwanga, J. A. G. Whitworth, A. M. Elliott, Effect of single-dose anthelmintic treatment during pregnancy on an infant’s response to immunisation and on susceptibility to infectious diseases in infancy: A randomised, double-blind, placebo-controlled trial. Lancet 377, 52–62 (2011).
23. B. Namara, S. Nash, S. A. Lule, H. Akurut, H. Mpairwe, F. Akello, J. Tumusiime, M. Kizza, J. Kabagenyi, G. Nkurunungi, L. Muhangi, E. L. Webb, M. Muwanga, A. M. Elliott, Effects of treating helminths during pregnancy and early childhood on risk of allergy-related outcomes: Follow-up of a randomized controlled trial. Pediatr. Allergy Immunol. 28, 784–792 (2017).
24. M. C. Nunes, C. L. Cutland, S. Jones, A. Hugo, R. Madimabe, E. A. F. Simões, A. Weinberg, S. A. Madhi, Duration of Infant Protection Against Influenza Illness Conferred by Maternal Immunization. JAMA Pediatr. 170, 840 (2016).
25. C. M. Bliss, A. Drammeh, G. Bowyer, G. S. Sanou, Y. J. Jagne, O. Ouedraogo, N. J. Edwards, C. Tarama, N. Ouedraogo, M. Ouedraogo, J. Njie-Jobe, A. Diarra, M. O. Afolabi, A. B. Tiono, J. B. Yaro, U. J. Adetifa, S. H. Hodgson, N. A. Anagnostou, R. Roberts, C. J. A. Duncan, R. Cortese, N. K. Viebig, O. Leroy, A. M. Lawrie, K. L. Flanagan, B. Kampmann, E. B. Imoukhuede, S. B. Sirima, K. Bojang, A. V. S. Hill, I. Nébié, K. J. Ewer, Viral vector malaria vaccines induce high-level T cell and antibody responses in west african children and infants. Mol. Ther. 25, 547–559 (2017).
26. S. H. Atkinson, K. Rockett, G. Sirugo, P. A. Bejon, A. Fulford, M. A. O’Connell, R. Bailey, D. P. Kwiatkowski, A. M. Prentice, Seasonal childhood anaemia in West Africa is associated with the haptoglobin 2-2 genotype. PLOS Med. 3, e172 (2006).
27. T. W. Mwangi, A. Ross, R. W. Snow, K. Marsh, Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J. Infect. Dis. 191, 1932–1939 (2005).
28. World Health Organization, “Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Vitamin and Mineral Nutrition Information System” (2011).
29. P. Ross, L. Hall, I. Smirnov, L. Haff, High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat. Biotechnol. 16, 1347–1351 (1998).
30. L. Zhang, X. Cui, K. Schmitt, R. Hubert, W. Navidi, N. Arnheim, Whole genome amplification from a single cell: Implications for genetic analysis. Proc. Natl. Acad. Sci. U.S.A. 89, 5847–5851 (1992).
31. B. Howie, J. Marchini, M. Stephens, Genotype imputation with thousands of genomes. G3 1, 457–470 (2011).
32. M. A. Clark, M. M. Goheen, A. Fulford, A. M. Prentice, M. A. Elnagheeb, J. Patel, N. Fisher, S. M. Taylor, R. S. Kasthuri, C. Cerami, Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nat. Commun. 5, 4446 (2014).
33. M. M. Goheen, R. Wegmüller, A. Bah, B. Darboe, E. Danso, M. Affara, D. Gardner, J. C. Patel, A. M. Prentice, C. Cerami, Anemia offers stronger protection than sickle cell trait against the erythrocytic stage of falciparum malaria and this protection is reversed by iron supplementation. EBioMedicine 14, 123–130 (2016).
34. World Health Organization, “Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Programme Managers” (2001).
35. K. Keenan, P. Mcginnity, T. F. Cross, W. W. Crozier, P. A. Prodöhl, diveRsity: An R package for the estimation and exploration of population genetics parameters and their associated errors. Methods Ecol. Evol. 4, 782–788 (2013).
36. E. Beutler, J. C. Barton, V. J. Felitti, T. Gelbart, C. West, P. L. Lee, J. Waalen, C. Vulpe, Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans. Blood Cells Mol. Dis. 31, 305–309 (2003).
37. L. McNamara, V. R. Gordeuk, A. P. MacPhail, Ferroportin (Q248H) mutations in African families with dietary iron overload. J. Gastroenterol. Hepatol. 20, 1855–1858 (2005).
38. I. Kasvosve, Z. Debebe, S. Nekhai, V. R. Gordeuk, Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor- and macrophage migration inhibitory factor concentrations in African children. Clin. Chim. Acta 411, 1248–1252 (2010).
39. P. B. Katchunga, M. Baguma, J.-R. M’Buyamba-kabangu, J. Philippé, M. P. Hermans, J. Delanghe, Ferroportin Q248H mutation, hyperferritinemia and atypical type 2 diabetes mellitus in South Kivu. Diabetes Metab. Syndr. Clin. Res. Rev. 7, 112–115 (2013).
40. J. C. Cikomola, M. R. Flórez, M. Costas-Rodríguez, Y. Anoshkina, K. Vandepoele, P. B. Katchunga, A. S. Kishabongo, M. M. Speeckaert, F. Vanhaecke, J. R. Delanghe, Whole blood Fe isotopic signature in a sub-Saharan African population. Metallomics 9, 1142–1149 (2017).